GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells

Author:

Chen Hsiang-Ju123ORCID,Huang Rui-Lan456ORCID,Liew Phui-Ly78ORCID,Su Po-Hsuan5,Chen Lin-Yu2,Weng Yu-Chun45,Chang Cheng-Chang39,Wang Yu-Chi39,Chan Michael Wing-Yan10ORCID,Lai Hung-Cheng145311ORCID

Affiliation:

1. Molecular and Cell Biology, Taiwan International Graduate Program; Academia Sinica and Graduate Institute of Life Science, National Defense Medical Center; Taipei Taiwan

2. National Defense Medical Center; Graduate Institute of Life Sciences; Taipei Taiwan

3. Department of Obstetrics and Gynecology; Tri-Service General Hospital; Taipei Taiwan

4. Department of Obstetrics and Gynecology; Shuang Ho Hospital, Taipei Medical University; New Taipei Taiwan

5. Translational Epigenetic Center; Shuang Ho Hospital, Taipei Medical University; New Taipei Taiwan

6. Department of Obstetrics and Gynecology; School of Medicine, College of Medicine, Taipei Medical University; Taipei Taiwan

7. Department of Pathology; Shuang Ho Hospital, Taipei Medical University; New Taipei Taiwan

8. Department of Pathology; School of Medicine, College of Medicine, Taipei Medical University; Taipei Taiwan

9. National Defense Medical Center; Graduate Institute of Medical Sciences; Taipei Taiwan

10. Department of Life Science; National Chung Cheng University; Chia-Yi Taiwan

11. Department of Obstetrics and Gynecology; School of Medicine, College of Medicine, Taipei Medical University; Taipei Taiwan. Department of Clinical Pharmacology; Xiangya Hospital, Central South University; Changsha People's Republic of China. Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology, Central South University; Changsha People's Republic of China

Funder

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Shuang Ho Hospital-Taipei Medical University

Taipei Medical University

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Epidemiology of epithelial ovarian cancer;Webb;Best Pract Res Clin Obstet Gynaecol,2017

2. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma;Singer;J Natl Cancer Inst,2003

3. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory;Kurman;Am J Surg Pathol,2010

4. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer;Tan;EMBO Mol Med,2013

5. The role of cancer stem cells and the side population in epithelial ovarian cancer;Fong;Histol Histopathol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3